{"id":"https://openalex.org/W5134286","doi":null,"title":"Vascular targeting therapy: potential benefit depends on tumor and host related effects.","display_name":"Vascular targeting therapy: potential benefit depends on tumor and host related effects.","alternate_titles":[],"publication_year":2010,"publication_date":"2010-09-01","ids":{"openalex":"https://openalex.org/W5134286","mag":"5134286","pmid":"https://pubmed.ncbi.nlm.nih.gov/21403608"},"language":"en","primary_location":{"id":"pmid:21403608","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21403608","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental oncology","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W5134286"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088517672","display_name":"Michael R. Horsman","orcid":"https://orcid.org/0000-0003-1578-5691","observed_orcids":["https://orcid.org/0000-0003-1578-5691"]},"institutions":[{"id":"https://openalex.org/I2802335433","display_name":"Aarhus University Hospital","ror":"https://ror.org/040r8fr65","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802335433"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M R Horsman","raw_affiliation_strings":["Department of Experimental Clinical Oncology, Aarhus University Hospital, DK-8000 Aarhus C, Denmark. mike@oncology.dk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Clinical Oncology, Aarhus University Hospital, DK-8000 Aarhus C, Denmark. mike@oncology.dk","institution_ids":["https://openalex.org/I2802335433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001734021","display_name":"Anja Bille Bohn","orcid":"https://orcid.org/0009-0006-3012-2094","observed_orcids":["https://orcid.org/0009-0006-3012-2094"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A B Bohn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5032701248","display_name":"Morten Busk","orcid":"https://orcid.org/0000-0001-5711-1017","observed_orcids":["https://orcid.org/0000-0001-5711-1017"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Busk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.5033,"has_fulltext":false,"cited_by_count":35,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.80234188,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"32","issue":"3","first_page":"143","last_page":"148"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11469","display_name":"Lymphatic System and Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vascular-targeting-agents","display_name":"vascular targeting agents","score":0.9049999713897705},{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.9419999718666077},{"id":"https://openalex.org/keywords/vascular-disrupting-agents","display_name":"vascular disrupting agents","score":1.0},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.8659999966621399},{"id":"https://openalex.org/keywords/tumor-vasculature","display_name":"tumor vasculature","score":0.7350000143051147},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6499999761581421},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.5659999847412109},{"id":"https://openalex.org/keywords/tumor-associated-neutrophils","display_name":"tumor-associated neutrophils","score":0.6240000128746033},{"id":"https://openalex.org/keywords/tumor-associated-mast-cells","display_name":"tumor-associated mast cells","score":0.6589999794960022},{"id":"https://openalex.org/keywords/cancer-associated-fibroblasts","display_name":"cancer-associated fibroblasts","score":0.8080000281333923},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.9860000014305115},{"id":"https://openalex.org/keywords/normal-tissue-toxicity","display_name":"normal tissue toxicity","score":0.7379999756813049}],"concepts":[{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.8209125995635986},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5694526433944702},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49543702602386475},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.49163728952407837},{"id":"https://openalex.org/C2778271429","wikidata":"https://www.wikidata.org/wiki/Q1281049","display_name":"Neovascularization","level":3,"score":0.4309133291244507},{"id":"https://openalex.org/C123012128","wikidata":"https://www.wikidata.org/wiki/Q5376430","display_name":"Endothelial stem cell","level":3,"score":0.41356873512268066},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38543272018432617},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.34132713079452515},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2970213294029236},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmid:21403608","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21403608","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:publications/f2e43698-9202-442f-a8c9-fd47cf4b0dbb","doi":null,"is_oa":false,"landing_page_url":"https://pure.au.dk/portal/en/publications/f2e43698-9202-442f-a8c9-fd47cf4b0dbb","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Horsman, M R, Bohn, A B & Busk, M 2010, 'Vascular targeting therapy: potential benefit depends on tumor and host related effects', Experimental Oncology, vol. 32, no. 3, pp. 143-8.","raw_type":"info:eu-repo/semantics/review"},{"id":"mag:5134286","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21403608","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W88448219","https://openalex.org/W1486740674","https://openalex.org/W1603230122","https://openalex.org/W1795179533","https://openalex.org/W1956944003","https://openalex.org/W1966726954","https://openalex.org/W1969950242","https://openalex.org/W1971697005","https://openalex.org/W1974448776","https://openalex.org/W1975815647","https://openalex.org/W1995827857","https://openalex.org/W1995837298","https://openalex.org/W1999392745","https://openalex.org/W2000292756","https://openalex.org/W2001009247","https://openalex.org/W2007912397","https://openalex.org/W2009530319","https://openalex.org/W2012560556","https://openalex.org/W2013818100","https://openalex.org/W2024328965","https://openalex.org/W2026087181","https://openalex.org/W2028437938","https://openalex.org/W2035056966","https://openalex.org/W2036564049","https://openalex.org/W2048707792","https://openalex.org/W2058920071","https://openalex.org/W2064360454","https://openalex.org/W2075180392","https://openalex.org/W2075448429","https://openalex.org/W2077694484","https://openalex.org/W2080621503","https://openalex.org/W2082773133","https://openalex.org/W2085281191","https://openalex.org/W2095729959","https://openalex.org/W2098282622","https://openalex.org/W2098856542","https://openalex.org/W2103763724","https://openalex.org/W2109434751","https://openalex.org/W2115538252","https://openalex.org/W2128186312","https://openalex.org/W2141892585","https://openalex.org/W2152574565","https://openalex.org/W2156701913","https://openalex.org/W2174845029","https://openalex.org/W2306993562","https://openalex.org/W2804842145"],"related_works":["https://openalex.org/W2036564049","https://openalex.org/W2052008300","https://openalex.org/W2152574565","https://openalex.org/W2128186312","https://openalex.org/W2751162660","https://openalex.org/W1763499759","https://openalex.org/W184128227","https://openalex.org/W2055040869","https://openalex.org/W1968515430","https://openalex.org/W2045464991"],"abstract_inverted_index":{"The":[0,31,239],"growth":[1,172],"and":[2,41,60,75,116,120,122,164,202,204,290,295,350,354],"development":[3,276],"of":[4,29,33,44,113,124,178,189,193,280,308,329,340,363],"most":[5],"solid":[6],"tumors":[7],"require":[8],"that":[9,52,62,174,211],"they":[10,18,95],"form":[11,279],"their":[12,88],"own":[13],"functional":[14],"vascular":[15,24,45],"supply,":[16],"which":[17,284],"do":[19],"from":[20,286],"the":[21,27,54,64,111,133,136,141,170,186,257,264,269,306,337,361],"host":[22,143,180,213,240,351],"normal":[23,142,258,331],"network":[25],"by":[26,221,334],"process":[28,56],"angiogenesis.":[30,176],"significance":[32],"this":[34,320,356],"neo-vasculature":[35],"makes":[36],"it":[37],"an":[38,146],"excellent":[39],"target":[40,137],"two":[42],"forms":[43],"targeting":[46],"agents":[47],"(VTAs)":[48],"have":[49,78,109,318],"evolved;":[50],"those":[51,61],"inhibit":[53],"angiogenesis":[55,190,234],"(angiogenesis":[57],"inhibitors,":[58],"AIs)":[59],"damage":[63,333],"already":[65],"established":[66],"vessels":[67,226],"(vascular":[68],"disrupting":[69],"agents,":[70],"VDAs).":[71],"Although":[72,132],"both":[73],"AIs":[74,115,228],"VDAs":[76,117],"can":[77,167,215],"substantial":[79],"anti-tumor":[80],"activity,":[81],"neither":[82],"induce":[83,277],"tumor":[84,134,225,233,349],"control,":[85],"thus":[86,256],"for":[87,138],"full":[89],"clinical":[90,130,275],"potential":[91],"to":[92,98,223,254,268,292,325],"be":[93,99],"achieved":[94],"will":[96,343,359],"need":[97],"combined":[100],"with":[101,118,237,321],"more":[102,293,300],"conventional":[103],"cancer":[104],"therapies.":[105],"Numerous":[106],"pre-clinical":[107,316],"studies":[108,317],"demonstrated":[110],"efficacy":[112],"combining":[114],"radio-":[119],"chemo-therapy":[121],"many":[123],"these":[125,179,212],"approaches":[126],"are":[127,229,251],"now":[128],"under":[129],"evaluation.":[131],"is":[135,208,304],"VTA":[139,150,218,341],"therapy":[140,250],"cells":[144,153,181,214],"play":[145],"important":[147,171],"role":[148],"in":[149,185,274,355],"efficacy.":[151],"Host":[152],"such":[154],"as":[155],"infiltrating":[156],"macrophages,":[157],"neutrophils,":[158],"mast":[159],"cells,":[160,163],"platelets,":[161],"endothelial":[162,199],"stromal":[165],"fibroblasts":[166],"all":[168],"produce":[169],"factors":[173],"initiate":[175],"Many":[177],"also":[182,216,242,305],"actively":[183],"participate":[184],"physical":[187],"steps":[188],"including":[191],"destabilization":[192],"existing":[194],"vessels,":[195],"blood":[196],"vessel":[197,205],"sprouting,":[198],"cell":[200],"migration":[201],"proliferation,":[203],"stabilization.":[206],"There":[207],"some":[209,278],"evidence":[210],"influence":[217],"treatment,":[219],"either":[220],"helping":[222],"normalize":[224],"when":[227],"administered":[230],"or":[231],"stimulate":[232],"after":[235],"treatment":[236,342],"VDAs.":[238],"itself":[241],"plays":[243],"a":[244,346],"critical":[245],"role.":[246],"Cancer":[247],"patients":[248],"undergoing":[249],"normally":[252],"treated":[253],"tolerance,":[255],"tissue":[259,312,332],"side":[260,282],"effects":[261],"actually":[262],"control":[263],"effective":[265],"dose":[266],"given":[267],"tumor.":[270],"All":[271],"VTAs":[272],"currently":[273],"systemic":[281],"effects,":[283,353],"range":[285],"being":[287],"rather":[288],"mild":[289],"tolerable":[291],"severe":[294],"even":[296],"life":[297],"threatening.":[298],"For":[299],"localised":[301],"therapies":[302],"there":[303],"issue":[307],"possible":[309],"VTA-enhanced":[310],"local":[311],"reactions.":[313],"A":[314],"few":[315],"investigated":[319],"radiation,":[322],"but":[323],"failed":[324],"show":[326],"any":[327],"enhancement":[328],"radiation-induced":[330],"VTAs.":[335],"Clearly,":[336],"therapeutic":[338],"benefit":[339],"depend":[344],"on":[345],"balance":[347],"between":[348],"related":[352],"review":[357],"we":[358],"consider":[360],"contribution":[362],"each.":[364]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W5134286","counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
